Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detecting Lung Cancer by Volatile Organic Compounds in Exhaled Breath: a Study of Lung Cancer Diagnostic Biomarker

NCT04419207 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT04419207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04419207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detecting Lung Cancer by Volatile Organic Compounds in Exhaled Breath: a Study of Lung Cancer Diagnostic Biomarker
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Completed
Start date
March 1, 2019
Completion date
January 31, 2022
Enrollment
2,236 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, lung cancer, lung neoplasms, nsclc